MedTrace Logo

Transversus Abdominus Plane Block

NCT01054469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2012-06-21

No results posted yet for this study

Summary

Transversus Abdominus Plane (TAP) block may reduce need for postoperative pain medications in patients undergoing laparoscopic hand assisted nephrectomy. Our hypothesis is that the TAP block will result in a significant reduction in pain scores and morphine requirements in the active group.

Conditions

  • Nephrectomy

Interventions

PROCEDURE

TAP block placement with placebo

20 ml of normal saline (placebo)

PROCEDURE

Placement of block with ropivacaine

20 ml of 0.5% ropivacaine hydrochloride

Sponsors & Collaborators

Principal Investigators

  • Stephen Aniskevich, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054469 on ClinicalTrials.gov